StratGraph
Companies / Financials
GS

Goldman Sachs

Investment Banking & Brokerage

Investment Banking & BrokerageAnalysis in progress
In progress

We are decoding this company's strategy and relationships

New analyses are published every weekday. Founding members get them first.

Business at a glance

Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work

Operating health79
Growth52
Profitability100
Cash generationn/a
Balance sheetn/a
Dilution control86
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)23.0%Revenue growth (FY)8.9%Revenue CAGR (3y)7.2%Gross margin—Operating margin—Net margin29.5%Free cash flow margin-81.0%R&D / revenue—Stock comp / revenue5.9%Net debt / operating cash flow—Current ratio—Diluted share count change-4.8%
Fiscal year endingFY 2021-12FY 2022-12FY 2023-12FY 2024-12FY 2025-12
Revenue$59.3B$47.4B$46.3B$53.5B$58.3B
Net income$21.6B$11.3B$8.5B$14.3B$17.2B
Operating cash flow$6.3B$8.7B-$12.6B-$13.2B-$45.2B
Capital expenditure$4.7B$3.7B$2.3B$2.1B$2.1B
Free cash flow$1.6B$5.0B-$14.9B-$15.3B-$47.2B
Stock-based comp$2.3B$4.1B$2.1B$2.7B$3.4B
Buybacks$5.2B$3.5B$5.8B$8.0B$12.4B
Dividends$2.7B$3.7B$4.2B$4.5B$5.3B
Cash$261.0B$241.8B$241.6B$182.1B$164.3B
Total debt$6.7B$61.0B$75.9B$69.7B—
Equity$109.9B$117.2B$116.9B$122.0B$125.0B

StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.